全球最老龄化社会中吸入性肺炎:日本全国登记中按年龄分层的ICU管理与结局
这项多中心回顾性观察队列研究基于日本重症患者数据库(JIPAD)2015-2023年数据,纳入3,906例以吸入性肺炎为主要诊断入ICU的成人(中位年龄76岁,75.5%男性)。随年龄增长,入ICU时病情严重度增加(APACHE III中位:18-64岁74 vs ≥85岁96),但有创机械通气使用率反而降低(18-64岁73.2% vs ≥85岁55.4%)。总体院内死亡率为28.3%,随年龄递增(18-64岁13.7%;65-74岁25.0%;75-84岁32.1%;≥85岁39.3%)。≥85岁患者在家出院率仅19.9%,远低于18-64岁的45.2%。探索性校正分析提示,年龄越大院内死亡概率越高,而机械通气概率越低(尤其在>75岁患者中)。
要点
- ≥85岁吸入性肺炎患者入ICU时APACHE III中位96(IQR 81-120),显著高于18-64岁的74(IQR 56-91),但接受有创机械通气比例更低(55.4% vs 73.2%)。
- 总体院内死亡率为28.3%,按年龄递增:18-64岁13.7%、65-74岁25.0%、75-84岁32.1%、≥85岁39.3%。
- ≥85岁患者在家出院率仅19.9%,而18-64岁为45.2%,提示高龄患者出院去向更依赖机构照护。
- 中位住院时间32天(IQR 16-58),中位ICU停留时间120.4小时(IQR 54.4-234.8),提示资源占用时间长。
- 探索性校正分析显示,年龄越大院内死亡概率越高,而机械通气概率越低,尤其>75岁患者。
适用人群与场景
- 年龄≥18岁、以吸入性肺炎为主要诊断收入ICU的成人患者;数据来自日本重症患者数据库(JIPAD)2015-2023年多中心ICU登记。
诊断标准与关键阈值
- 原文未提及吸入性肺炎的具体诊断标准或评分界值。
处置流程与药物剂量
- 有创机械通气使用率:总体68.8%;18-64岁73.2%;65-74岁74.2%;75-84岁69.9%;≥85岁55.4%。
- 探索性校正分析提示,年龄>75岁患者接受机械通气的概率降低。
红旗征与不能漏的情况
- 原文未提及需要立刻处理或不能漏诊的具体红旗征。
研究设计与关键结果
- 研究类型:多中心、回顾性、观察性队列研究;样本量3,906例ICU入住;数据来自日本重症患者数据库(JIPAD)全国登记,2015-2023年。
- 人群:成人(≥18岁)以吸入性肺炎为主要诊断入ICU;中位年龄76岁(IQR 68-83),75.5%男性。
- 主要终点结果:总体院内死亡率28.3%;按年龄分层:18-64岁13.7%、65-74岁25.0%、75-84岁32.1%、≥85岁39.3%。
- 关键次要终点:有创机械通气总体68.8%,18-64岁73.2%、65-74岁74.2%、75-84岁69.9%、≥85岁55.4%;≥85岁在家出院率19.9% vs 18-64岁45.2%;中位住院时间32天(IQR 16-58),中位ICU停留120.4小时(IQR 54.4-234.8)。
- 探索性校正分析:年龄越大院内死亡概率越高,机械通气概率越低(尤其>75岁患者)。
证据类型、等级与局限
- 证据类型:多中心回顾性观察性队列研究(基于全国登记数据库)。
- 局限:回顾性设计;观察性研究不能推断因果;探索性校正分析结果需前瞻性验证;原文未提及其他局限。
对床旁实践的改变
- 原文数据提示,高龄(尤其≥85岁)吸入性肺炎患者入ICU时病情更重但机械通气使用更少,临床决策中需关注年龄相关的治疗强度差异。
- 高龄患者院内死亡率高(≥85岁39.3%)、在家出院率低(19.9%),与家属沟通预后和出院去向时可参考这些数据。
- 原文未提及能改变的具体治疗措施或药物使用。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To describe the age-stratified clinical characteristics, ICU management, and in-hospital outcomes of adults admitted to Japanese ICUs with aspiration pneumonia.
DESIGN: Multicenter, retrospective, observational cohort study.
SETTING: Multiple ICUs participated in the Japanese Intensive Care Patient Database (JIPAD), a nationwide registry of the Japanese Society of Intensive Care Medicine, from 2015 to 2023.
PATIENTS: Adults ≥ 18 years admitted to ICUs with a primary diagnosis of aspiration pneumonia.
MEASUREMENTS AND MAIN RESULTS: Among 3,906 eligible ICU admissions (median age, 76 years [IQR, 68-83]; 75.5% male), illness severity at admission increased with age (median APACHE III score, 74 [56-91] in patients aged 18-64 years vs. 96 [81-120] in those aged ≥ 85 years). Invasive mechanical ventilation (MV) was used in 68.8% of patients and was less frequent in older age groups (18-64 years: 73.2%; 65-74 years: 74.2%; 75-84 years: 69.9%; ≥ 85 years: 55.4%). Overall in-hospital mortality was 28.3% and increased across age groups (18-64 years: 13.7%; 65-74 years: 25.0%; 75-84 years: 32.1%; ≥ 85 years: 39.3%). Median hospital and ICU lengths of stay were 32 days (IQR, 16-58) and 120.4 h (IQR, 54.4-234.8), respectively. In-hospital pathways differed markedly across age groups: among patients aged ≥ 85 years, in-hospital mortality reached 39.3%, and home discharge was achieved in only 19.9%, compared with 13.7% and 45.2% among patients aged 18-64 years, respectively. In the exploratory adjusted analyses, the probability of in-hospital mortality increased with age, whereas that of MV use decreased, particularly in patients aged > 75 years.
CONCLUSIONS: Older patients with aspiration pneumonia had higher illness severity yet received less MV, and had higher in-hospital mortality and lower home discharge rates. These nationwide data describe the current state of ICU-managed aspiration pneumonia in a super-aged society and may provide a reference point for future comparative studies.
参考来源
- Sekiya S, Goto S, Okano H, et al. Aspiration pneumonia in the world's most aged society: age-stratified ICU management and outcomes from a nationwide Japanese registry. J Intensive Care. 2026. PMID: 42687219. doi:10.1186/s40560-026-00923-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。